Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank92
Studio
Year-over-Year Change

Free cash flow yield

Latest
0.66%
↑ 102% vs avg
Percentile
P92
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
-31.80%
Historical baseline
PeriodValueYoY Change
20250.66%+100.6%
2024-115.37%-65.0%
2023-69.94%-77.4%
2022-39.43%-10365.3%
2021-0.38%+92.2%
2020-4.82%+87.9%
2019-39.67%-12.7%
2018-35.18%-79.9%
2017-19.55%-443.9%
20165.69%-